Member Info for Winit

Just be that today will be results day !!

RICH3R "I don’t know how long the ‘use by date’ is for SNG001"
I have read the shelf life for SNG001 is 3 years refrigerated, 5 years frozen. Can anyone confirm?

Hopefully they liked what they saw and

the need to fill the roles sooner rather than later !!

Who knows.

Like it Hop2......aligns with the old adage

."Cream rises to the top"

Not long now hopefully.

Thanks for your thoughts BC and Manifesto.

Fair comment Kevin.......so RM wants (needs?) to wait for the Sprinter results AND SNG001 use in the hospitalised setting ?

I was thinking about Synairgens UK trials in relation to patient numbers not Activ trials, which probably blows my own thoughts out of the water?

Reading the posts makes me wonder why Lilly get bebtelovimab EUA approved prior to P3 trials/results.
A thought of mine: Could it be due to good P2 results (for it's own setting usage), combined with relatively large numbers of patients I.e being a large pharma have they been able to recruit and finance larger patient numbers in a P2 trial than Syn could afford to do? If so? Has this helped convince the approvers of its efficacy?
Sorry if that's not a potentially valid reason but I can't help wondering what is the reason., other than just simply the weight/influencers a large pharma will have.

We ain't got long to wait, tomorrow may be the big day.

Thanks again to ALL for the research information shared, always good to debate it nicely !!

Have a chilling Sunday, we may expend a lot of nervous (hopefully euphoric) energy tomorrow. If not "Que Sera Sera"

Regards to all.

Doc, the last link you posted is a fascinating read. A great link, thank you.
Very interesting to see the world from the China/Russian perspective instead of the West.

Andybe4. The only cringeworthy post in this thread is yours.
I am acutely aware of why we need this drug to treat patients that are seriously ill. Arrogant of you to suggest otherwise.
I always try to be open minded and give people the benefit of the doubt, however your post is totally unjustified and undignified.

Thanks gggg21 for this and your previous other posts. Twitter post from the Director no less !!
There must be something in this interferon theory haha.

Cheers Matt.
Always appreciate the quality of your posts/comments.
Doc......probably fair comment, I concede.

Thanks Matt, appreciate update. Source of info?

Fruits apologies for late reply regarding my previous post on this thread. As there seems to be some level of continued interest on this topic (There's a separate thread around this point now). I assume you will now know the somewhat tenuous link being made.......SNG in USA new company? Separate CEO required for that?
The guy lives relatively close to Delaware (Boston, just up the coast)

Stranger things could happen. Would they be able to announce appt of a new CEO before P3 results issue, would that be too obvious ?

JD76 post related:
https://www.takeda.com/who-we-are/company-information/executive-leadership/rajeev-venkayya/

He lives in Boston USA, quite close to Delaware!
Perhaps RM will retire on his fortune haha.

Hop2....like it.....its all a giggle !!

Hop2, I believe I understand your question but am unable to give you the best answer ( I think some have possibly misunderstood your request).
Like you I think but don't know, the best way would be to just sit there repeatedly requesting a quote until it get's quoted. I also would like to know if there is a better way.
The premise of your question being how to buy whilst a very large share price increase is taking place?

FTC7, apologies for any confusion I may have caused regarding "patient groups" I meant to say different patient settings (I.e. Home and hospital). I didn't mean anything else.

HSD, as sng170 states. Active is for home use.
Sprinter for different patient group, so again I wonder why the trial would not proceed ( if they are not ??).